drugset / Trial / NCT07242781

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

NCT07242781

Phase 1 Terminated 22 enrolled Celgene Corporation
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of Itraconazole and Rifampin on the drug levels of AR-LDD (BMS-986365) in healthy adult male participants.

Timeline

Start
2025-12-15
Primary completion
2026-04-09
Completion
2026-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject CC-94676 Other / unclassified
Subject Itraconazole Small molecule
Subject Rifampin Small molecule

Indications

No indication recorded.